Steve Brine MP

for Winchester & Chandler's Ford

25 JAN 2018

Steve Brine launches landmark review into prescription drug addiction

The growing problem of dependence and addiction to prescription drugs is set to form the basis of an independent review announced today by the Government, as stark figures show one patient in eleven was prescribed a potentially addictive drug last year alone.

Public Health Minister, Steve Brine, has commissioned Public Health England (PHE) to undertake a thorough evidence review along with recommendations on how to address it.

The review will consider why prescribing of addictive medicines has increased 3% over five years, and why one patient in eleven (8.9%) is prescribed one of these medicines. In addition, it will look at why antidepressant prescriptions in England have more than doubled in the past 10 years, and look into a recent survey which also found that 7.6% of adults had taken a prescription-only painkiller not prescribed to them.

PHE will assess the scale of the problem, the harms caused by dependence and withdrawal, how they may be prevented and the best way to respond.

Many people benefit from medicines that treat problems like pain, anxiety and insomnia. But some of these medicines are highly addictive and result in dependence and withdrawal.

Public Health Minister, Steve Brine said: "We know this is a huge problem in other countries like the United States—and we must absolutely make sure it doesn't become one here.

"While we are world-leading in offering free treatment for addiction, we cannot be complacent—that's why I've asked PHE to conduct this review.

"PHE has an excellent track record in robust evidence reviews, and this will help us understand the scale of this issue here and how we can address it."

Director of Drugs, Alcohol and Tobacco at PHE, Rosanna O'Connor, said: "It is of real concern that so many people find themselves dependent on or suffering withdrawal symptoms from prescribed medicines. Many will have sought help for a health problem only to find later on they have a further obstacle to overcome.

"PHE very much welcomes this opportunity as it is vital that we have the best understanding possible of how widespread these problems are, the harms they cause, as well as the most effective ways to prevent them happening and how best to help those in need."

The review will cover benzodiazepines and z-drugs, pregabalin and gabapentin, opioid pain medicines and antidepressants. While anti-depressants are generally not recognised to be dependence forming, some patients experience difficulties when they try to stop taking them. For some, the symptoms of this 'discontinuation syndrome' are severe.

It will be a broad, public-health focused review of commonly prescribed medicines for adults who have pain (excluding pain from cancer), anxiety, insomnia or depression. Patient and prescription data, peer-reviewed published evidence and guidance will be analysed to determine, prevalence and prescribing, the nature and likely causes of dependence or withdrawal, and effective prevention and treatment responses.

PHE will also consult with health professionals and people affected by the problem, including those supporting others to overcome it. The findings of the review will be published in early 2019.

Back to all posts


Upcoming Business – Commons: Select Committee (27 Feb 2018)
Petitions: Petition on the meningitis B vaccine. 2:15 pm; Room 8, Palace of Westminster
Witnesses: Steve Brine MP, Parliamentary Under Secretary of State for Public Health and Primary Care, Department of Health and Social Care Chris Mullin, Chief Economist, Department of Health and Social Care Dr Mary Ramsay, Consultant Epidemiologist and Head of Immunisation, Public Health England

Written Answers — Department of Health and Social Care: Influenza: Vaccination (23 Feb 2018)
Steve Brine: NHS England wrote to general practitioners and community pharmacists on 5 February to advise on which vaccines should be ordered for the 2018-19 flu season. This was based on new advice from the Joint Committee on Vaccination and Immunisation, evidence from Public Health England and the availability of a new adjuvanted trivalent vaccine (aTiv) for the 2018/19 season. Vaccine suppliers have...

Written Answers — Department of Health and Social Care: Medical Treatments: Innovation (23 Feb 2018)
Steve Brine: Since the publication of the independent review of the Early Access to Medicines Scheme (EAMS) the Government has made a number of improvements. Partners have worked together to provide updated guidance on the benefits and entry requirements for EAMS and are developing further guidance on collecting real world data in the scheme to support the National Institute for Health and Care Excellence...


Contact Steve Brine in Westminster

Call your MP in his Commons office on 0207 219 7189 or email steve.brine.mp@parliament.uk

Early Day Motions (EDMs)

Steve Brine does not sign EDMs - click here to read why.

Facebook

Sign up to e-newsletter

Sign up for email updates:

First name: *

Last name: *

Email: *

Postcode: *